abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2023年4月5日

作者:
B4Ukraine Coalition

Letter to Eli Lilly regarding its ongoing business activities in Russia

...We write to you as B4Ukraine, a coalition of Ukrainian and international civil society organizations working to curtail the financial resources enabling the Russian invasion of Ukraine. In the spirit of respect for the fundamental rights of all people, the rules-based international order, and a prosperous global economy, we expect companies to demonstrate public support for the people, democracy, and territorial integrity of Ukraine, opposition to Russia’s war of aggression, and alignment with the UN Guiding Principles on Business and Human Rights (UNGPs).

We request an urgent dialogue regarding potential inconsistencies between Eli Lilly’s obligations under international humanitarian and human rights law and the company’s ongoing business operations and relationships in Russia that may contribute to, or be linked with, human rights harms...

While we understand that Eli Lilly claims that its reason for continuing operations in the country is providing essential goods, the ‘essentiality argument’ is under increasing scrutiny. For example, Professor Jeffrey Sonnenfeld of Yale University challenges these explanations by stating that the reasons are “misguided at best, cynical in the medium case, and outright deplorably misleading and deceptive”...

We seek to understand the status of Eli Lilly’s exposure to Russia and how Eli Lilly has conducted and continues to conduct heightened human rights due diligence, and how the findings of such a process have resulted in these continued business activities and relationships...

時間線

隱私資訊

本網站使用 cookie 和其他網絡存儲技術。您可以在下方設置您的隱私選項。您所作的更改將立即生效。

有關我們使用網絡儲存技術的更多資訊,請參閱我們的 數據使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析cookie

ON
OFF

您瀏覽本網頁時我們將以Google Analytics收集信息。接受此cookie將有助我們理解您的瀏覽資訊,並協助我們改善呈現資訊的方法。所有分析資訊都以匿名方式收集,我們並不能用相關資訊得到您的個人信息。谷歌在所有主要瀏覽器中都提供退出Google Analytics的添加應用程式。

市場營銷cookies

ON
OFF

我們從第三方網站獲得企業責任資訊,當中包括社交媒體和搜尋引擎。這些cookie協助我們理解相關瀏覽數據。

您在此網站上的隱私選項

本網站使用 cookie 和其他網絡儲存技術來增強您在必要核心功能之外的體驗。